Ellington Management Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-62,900
Closed -$687K 351
2020
Q1
$687K Buy
+62,900
New +$1.16M 0.16% 177
2019
Q4
Sell
-13,400
Closed -$308K 728
2019
Q3
$308K Buy
+13,400
New +$286K 0.06% 360
2017
Q2
Sell
-11,300
Closed -$316K 872
2017
Q1
$316K Buy
+11,300
New +$296K 0.01% 449
2016
Q4
Sell
-16,400
Closed -$413K 773
2016
Q3
$413K Buy
+16,400
New +$393K 0.11% 345
2013
Q4
Sell
-15,500
Closed -$357K 758
2013
Q3
$357K Buy
+15,500
New +$382K 0.07% 448

Other funds holding SBRA

Ellington Management Group's SBRA Position: Q2 2020 in Review

Ellington Management Group sold out of Sabra Healthcare REIT (SBRA) in Q2 2020, closing a stake of 62,900 shares — an estimated $687K sold.

Ellington Management Group first reported a position in SBRA in Q3 2013 and held it in 5 quarters. The position peaked at $687K in Q1 2020. 317 funds tracked by Wall St. Rank hold SBRA as of Q2 2020.

  • Ellington Management Group reported no remaining Sabra Healthcare REIT position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 62,900 Sabra Healthcare REIT shares in Q2 2020, an estimated $687K.
  • Ellington Management Group first reported a position in Sabra Healthcare REIT in Q3 2013 and held it in 5 quarters.
  • Ellington Management Group's Sabra Healthcare REIT position peaked at $687K in Q1 2020.
  • 317 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.